The uptick in Leqembi (lecanemab) sales comes a few months after the FDA approved a once-weekly subcutaneous injection ...

Bayer is vying to be first to market in the oral Factor XIa category against Bristol Myers Squibb and Johnson & Johnson, ...

Telehealth company GoodRx said it is a "core integration partner" for TrumpRx, providing access to around 30 of Pfizer's ...

European biotechs continue to face a demanding investment climate characterised by investor caution. As a result, many are ...

There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, ...

A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can be used routinely by the NHS to monitor patients with ...

Incubated by Flagship Pioneering, Generate applies AI to teasing out the three-dimensional structure of human proteins, ...

Pharma digital success is still largely defined by top level engagement metrics such as page visits, time on page, and ...

Galleri is a multi-cancer early detection (MCED) or 'liquid biopsy' test that Grail says can spot signs of up to 50 different ...

Sam Possemiers, CEO of MRM Health, believes that the space is finally coming into maturity. At his own company, that’s in the ...

Acute pancreatitis is linked to the development of gallstones, which are listed as a side effect with GLP-1 drugs. Ahmed said ...

On Amgen's call, the company's head of R&D, Jay Bradner, said the FDA's request for a voluntary withdrawal on 16th January ...